Allogeneic Cord Blood Cells for Adults With Severe Acute Contusion Spinal Cord Injury

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
Study evaluates the safety and primary efficiency of systemic (i.v.) allogeneic human umbilical cord blood mononuclear cell infusions in patients with severe acute contusion spinal cord injury (ASIA A/B). 20 patients were included. Half of patients received cell therapy in addition to standard therapy, while the other half received standard therapy only.
Epistemonikos ID: 451ffe70343e99da95ec5e58c14e29546f0355e0
First added on: May 07, 2024